Adrenomedullin and nitrite levels in children with dilated cardiomyopathy

Pediatric Cardiology

Volumn 24, Issue 4, 2003, Pages 381-385

  Kilinc M ^a   Balat, A ^a   Cekmen M ^b   Yurekli M ^c   Yilmaz, K ^a   Sahinoz S ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

^c INONU UNIVERSITY   (Turkey)

Author keywords

Adrenomedullin; Children; Dilated cardiomyopathy; Nitric oxide

Indexed keywords

ADRENOMEDULLIN; NITRIC OXIDE; NITRITE;

ALDOSTERONE RELEASE; ARTICLE; CELL VIABILITY; CHILD; CLINICAL ARTICLE; CREATININE CLEARANCE; FEMALE; HEART DILATATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE OXYGEN CONSUMPTION; HORMONAL REGULATION; HUMAN; IDIOPATHIC DISEASE; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; MEDIATOR RELEASE; VASCULAR RESISTANCE; VASOMOTOR REFLEX;

ADOLESCENT; ADRENOMEDULLIN; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEART FUNCTION TESTS; HUMANS; MALE; NITRIC OXIDE; PEPTIDES; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0042470915     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-002-0352-8     Document Type: Article

References (29)

1. Baumer AT, Schumann C, Cremers B, et al. (2002) Gene expression of adrenomedullin in failing myocardium: comparison to atrial natriuretic peptide. J Appl Physiol 92:1058-1063
2. Bories PN, Bories C (1995) Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem 41:904-907
3. Cheung B, Leung R (1997) Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clin Sci 92:59-62
4. Etoh T, Kato J, Takenaga M, et al. (1999) Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels. Clin Cardiol 22:113-117
5. Habib FM, Spingall DR, Davies GJ, et al. (1998) Tumor necrosis factor and inducible nitric oxide syntheses in dilated cardiomyopathy. Lancet 347:1151-1155
6. Hamada M, Shigematsu Y, Kawakami H, et al. (1998) Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: its relation to endothelin-1, natriuretic peptides and noradrenaline. Clin Sci 94:21-28
7. Heywood GA, Tsolo PS, von der Leyer HE, et al. (1996) Expression of inducible nitric oxide syntheses in human heart failure. Circulation 93:1087-1094
8. Heymes C, Vanderheyden M, Bronzwaer JG, Shah AM, Paulus WJ (1999) Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation 99:3009-3016
9. Ikeda U, Shimada K (1997) Nitric oxide and cardiac failure. Clin Cardiol 20:837-841
10. Ishimitu T, Nishikimi T, Kitamura K, et al. (1994) Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 94:2158-2161
11. Kangawa K, Kitamura K, Minamino N, Eto T, Matsuo H (1996) Adrenomedullin: a new hypotensive peptide. J Hypertension 14:S105-S110
12. Kitamura K, Kangawa K, Kawamoto M, et al. (1993) Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553-560
13. Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236-241
14. Manolio TA, Baughman KL, Rodenheffer R (1992) Prevalence and etiology of idiopathics dilated cardiomyopathy (summary of a National Heart Lung and Blood Institute workshop). Am J Cardiol 69:1458-1466
15. Mant CT, Hudges RS (1991) High Performance Liquid Chromotography of Peptides and Proteins. CRC Press, Boca Raton, FL
16. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142
17. Pousset F, Masson F, Chavirovskaia O, et al. (2000) Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure. Eur Heart J 21:1009-1014
18. Rakhit RD, Tousoulis D, Lefroy DC, Davies GJ (1999) Differential nitric oxide synthase activity in ischemic and idiopathic dilated cardiomyopathy. Am J Cardiol 84:737-738
19. Rhodes P, Leone AM, Francis PL, et al. (1995) The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun 209:590-596
20. Samson WK (1999) Adrenomedullin and the control of fluid and electrolyte homeostasis. Annu Rev Physiol 61:363-389
21. Sato K, Hirata Y, Imai T, Iwashina M, Marumo F (1995) Characterization of immunoreactive adrenomedullin in human plasma and urine. Life Sci 57:189-194
22. Sherman AJ, Davis III CA, Klocke FJ, et al. (1997) Blockade of nitric oxide synthesis reduces myocardial oxygen consumption in vivo. Circulation 95:1328-1334
23. Szekely L, Vijay P, Sharp TG, Bando K, Brown JW (2000) Correlation of plasma adrenomedullin to myocardial preservation during open-heart surgery. Pediatr Cardiol 21:228-233
24. Venugopalan P, Agarwal AK, Worthing EA (2000) Chronic cardiac failure in children due to dilated cardiomyopathy: diagnostic approach, pathophysiology and management. Eur J Pediatr 159:803-810
25. Veszelovsky E, Holford NH, Thomsen LL, Knowles RG, Baguley BC (1995) Plasma nitrate clearance in mice: modeling of the systemic production of nitrate following the induction of nitric oxide synthesis. Cancer Chemother Pharmacol 36:155-159
26. Winlaw DS, Smythe GA, Keogh AM, et al. (1994) Increased nitric oxide production in heart failure. Lancet 344:373-374
27. Xie Y-W, Shen W, Zhao G, et al. (1996) Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Circ Res 79:381-387
28. Zhang X, Xie Y-W, et al. (1997) ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation 95:176-182
29. Zhao G, Shen W, Zhang X, Smith CJ, Hintze TH (1996) Loss of nitric oxide production in the coronary circulation after the development of dilated cardiomyopathy: a specific defect in the neural regulation of coronary blood flow. Clin Exp Pharmacol Physiol 23:715-721